Anne Vivian-Scott
Vorstandsvorsitzender bei BKIN Technologies Ltd.
Profil
Anne Vivian-Scott is currently the President & Chief Executive Officer at BKIN Technologies Ltd.
She previously worked as the Vice President-Commercial Development at PARTEQ Innovations.
Ms. Vivian-Scott completed her undergraduate degree at The University of Waterloo.
Aktive Positionen von Anne Vivian-Scott
Unternehmen | Position | Beginn |
---|---|---|
BKIN Technologies Ltd.
BKIN Technologies Ltd. BiotechnologyHealth Technology BKIN Technologies Ltd. develops robotic technology for sensor motor neuroscience. It allows them to study, with exquisite precision, the sensory, motor and cognitive impact of a wide range of brain injuries and diseases, such as: stroke, cardiac arrest, transient ischemic attack, traumatic brain injury and Parkinson’s disease. The firm products are KINARMA exoskeleton, end point labs, dexterity-E and standard test. The company was founded by Stephen Scott and Ian Brown in 2004 and is headquartered in Kingston, Canada. | Vorstandsvorsitzender | 01.01.2009 |
Ehemalige bekannte Positionen von Anne Vivian-Scott
Unternehmen | Position | Ende |
---|---|---|
PARTEQ Innovations
PARTEQ Innovations Investment ManagersFinance Founded in 1987 by Queen's University at Kingston, Ontario, PARTEQ Innovations is a venture capital firm. | Corporate Officer/Principal | - |
Ausbildung von Anne Vivian-Scott
The University of Waterloo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
PARTEQ Innovations
PARTEQ Innovations Investment ManagersFinance Founded in 1987 by Queen's University at Kingston, Ontario, PARTEQ Innovations is a venture capital firm. | Finance |
BKIN Technologies Ltd.
BKIN Technologies Ltd. BiotechnologyHealth Technology BKIN Technologies Ltd. develops robotic technology for sensor motor neuroscience. It allows them to study, with exquisite precision, the sensory, motor and cognitive impact of a wide range of brain injuries and diseases, such as: stroke, cardiac arrest, transient ischemic attack, traumatic brain injury and Parkinson’s disease. The firm products are KINARMA exoskeleton, end point labs, dexterity-E and standard test. The company was founded by Stephen Scott and Ian Brown in 2004 and is headquartered in Kingston, Canada. | Health Technology |